The use of Sirolimus for an unresectable and refractory venous malformation: A case series
Abstract Vascular malformations (VM) may become symptomatic and extensive, leading to deranged coagulation and bleeding. Sirolimus®, an antiangiogenic agent, has recently emerged as treatment for VM. We report its short-term…